TABLE 1.

Plasma Levels of Lipids, Lipoproteins, and HDL Subfractions at the End of the Placebo, Estrogen, and Estrogen Plus Progestin Treatments in 8 Postmenopausal Women

	Placebo	CEE	CEE+MPA	% Change CEE vs Placebo	% Change CEE+MPA vs Placebo	% Change CEE+MPA vs CEE
TC, mmol/L	6.20±0.93	5.53±0.67	5.27±0.67	−9±17	−13±16	−5±6
TG, mmol/L	1.64±0.81	1.78±1.00	1.58±0.54	+16±41	+12±50	+2±46
LDL-C, mmol/L	3.54±0.93	2.95±0.78	2.87±0.80	−14±20	−17±21	−2±9
HDL-C, mmol/L	1.50±0.52	1.66±0.49*	1.55±0.52‡	+13±11	+6±13	−6±6
HDL2-C, mmol/L	0.52±0.39	0.66±0.34†	0.54±0.36	+37±43	+21±44	−13±16
HDL3-C, mmol/L	0.96±0.21	1.00±0.16	1.00±1.26	+7±17	+6±23	−1±13
ApoA-I, g/L	1.40±0.24	1.61±0.23*	1.50±0.25†‡	+19±16	+10±14	−7±6
LpAI, g/L	0.53±0.15	0.65±0.20*	0.55±0.17‡	+26±19	+6±15	−18±16
LpAI:AII, g/L	0.88±0.11	0.96±0.10	0.95±0.10†	+10±12	+9±8	0±11

Data are presented as mean±SD

Significantly different from placebo:

^*P<0.02,

^†P<0.05.

Significantly different from CEE:

^‡P<0.05.